Search research articles
Contact Us
Filters
Showing results (51-60 of 130) with videos related to
Page
of 13
Sort By:
Journal of Pain and Symptom Management
|
November 5, 2016
Frequency and Predictors of Acute Hospitalization Before Death in Patients With Glioblastoma
Eli L Diamond, Katherine S Panageas, Alexis Dallara, et al.
Neuro-Oncology Advances
|
July 10, 2020
Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy
Roei D Mazor, Ran Weissman, Judith Luckman, et al.
Neuro-Oncology Practice
|
October 1, 2021
Ethics consultations in neuro-oncology
Ugur Sener, Elizabeth C Neil, Amy Scharf, et al.
Journal of Psychosocial Oncology Research and Practice
|
February 10, 2025
Effects of a communication skills training program to improve capacity to engage in advance care planning in caregivers of patients with malignant gliomas
Allison J Applebaum, Morgan J Loschiavo, Amanda Kastrinos, et al.
Haematologica
|
December 4, 2025
Unemployment in patients with histiocytic neoplasms is frequent and associated with clinical and treatment characteristics
Anne S Reiner, Dana Bossert, Allison M Sigler, et al.
Molecular Cancer Therapeutics
|
April 25, 2019
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis
Filip Janku, Eli L Diamond, Aaron M Goodman, et al.
International Journal of Molecular Sciences
|
October 28, 2023
Erdheim-Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib
José A Riancho, José L Hernández, Carmen González-Vela, et al.
Ophthalmology. Retina
|
June 8, 2021
Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy
Jasmine H Francis, Julia Canestraro, Dianna Haggag-Lindgren, et al.
Leukemia
|
June 24, 2023
CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition
Eli L Diamond, Jasmine H Francis, Mario E Lacouture, et al.
Nature Immunology
|
December 14, 2019
The coming of age of Langerhans cell histiocytosis
Carl E Allen, Peter C L Beverley, Matthew Collin, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 130) with videos related to
Sort By:
Page
of 13
Journal of Pain and Symptom Management
|
November 5, 2016
Frequency and Predictors of Acute Hospitalization Before Death in Patients With Glioblastoma
Eli L Diamond, Katherine S Panageas, Alexis Dallara, et al.
Neuro-Oncology Advances
|
July 10, 2020
Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy
Roei D Mazor, Ran Weissman, Judith Luckman, et al.
Neuro-Oncology Practice
|
October 1, 2021
Ethics consultations in neuro-oncology
Ugur Sener, Elizabeth C Neil, Amy Scharf, et al.
Journal of Psychosocial Oncology Research and Practice
|
February 10, 2025
Effects of a communication skills training program to improve capacity to engage in advance care planning in caregivers of patients with malignant gliomas
Allison J Applebaum, Morgan J Loschiavo, Amanda Kastrinos, et al.
Haematologica
|
December 4, 2025
Unemployment in patients with histiocytic neoplasms is frequent and associated with clinical and treatment characteristics
Anne S Reiner, Dana Bossert, Allison M Sigler, et al.
Molecular Cancer Therapeutics
|
April 25, 2019
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis
Filip Janku, Eli L Diamond, Aaron M Goodman, et al.
International Journal of Molecular Sciences
|
October 28, 2023
Erdheim-Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib
José A Riancho, José L Hernández, Carmen González-Vela, et al.
Ophthalmology. Retina
|
June 8, 2021
Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy
Jasmine H Francis, Julia Canestraro, Dianna Haggag-Lindgren, et al.
Leukemia
|
June 24, 2023
CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition
Eli L Diamond, Jasmine H Francis, Mario E Lacouture, et al.
Nature Immunology
|
December 14, 2019
The coming of age of Langerhans cell histiocytosis
Carl E Allen, Peter C L Beverley, Matthew Collin, et al.
Page
of 13